about
Dysfunction of human Rad18 results in defective postreplication repair and hypersensitivity to multiple mutagensIncreased copy number at 3p14 in breast cancerOrganization, chromosomal localization and promoter analysis of the gene encoding human acidic fibroblast growth factor intracellular binding proteinActivation of the PI3K pathway in cancer through inhibition of PTEN by exchange factor P-REX2aActivation of the human homologue of the Drosophila sina gene in apoptosis and tumor suppressionA molecular analysis by gene expression profiling reveals Bik/NBK overexpression in sporadic breast tumor samples of Mexican femalesSingle and Multiple Gene Manipulations in Mouse Models of Human CancerMMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathwaysGene characterization, promoter analysis, and chromosomal localization of human bleomycin hydrolaseChromosome 3p allele loss in early invasive breast cancer: detailed mapping and association with clinicopathological features.DNA sequence copy number aberrations associated with histological subtypes and DNA ploidy in gastric carcinoma.Mammary tumor induction and premature ovarian failure in ApcMin mice are not enhanced by Brca2 deficiency.Loss of heterozygosity at the ATBF1-A locus located in the 16q22 minimal region in breast cancerData perturbation independent diagnosis and validation of breast cancer subtypes using clustering and patterns.Decoding pooled RNAi screens by means of barcode tiling arrays.The genetic basis of breast cancer and its clinical implications.Chromosomes, 11Q and cancer: a review.Assessing the Racial and Ethnic Disparities in Breast Cancer Mortality in the United StatesMammary gland neoplasia: insights from transgenic mouse models.Initiating oncogenic event determines gene-expression patterns of human breast cancer modelsSpecific protection against breast cancers by cyclin D1 ablation.Transgenic mouse models of human breast cancer.Mutation analysis of novel human liver-related putative tumor suppressor gene in hepatocellular carcinoma.DNA damage drives an activin a-dependent induction of cyclooxygenase-2 in premalignant cells and lesions.Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases.JAB1/CSN5: a new player in cell cycle control and cancerCytogenetic clues to breast carcinogenesis.Genetic determination of susceptibility to estrogen-induced mammary cancer in the ACI rat: mapping of Emca1 and Emca2 to chromosomes 5 and 18.FOXP1 inhibits cell growth and attenuates tumorigenicity of neuroblastoma.Genetic aberrations in hypodiploid breast cancer: frequent loss of chromosome 4 and amplification of cyclin D1 oncogeneHigh frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer.Genetic changes in intraductal breast cancer detected by comparative genomic hybridization.Genetic heterogeneity of primary and metastatic breast carcinoma defined by fluorescence in situ hybridization.Monosomy of chromosome 8 could be considered as a primary preneoplastic event in breast cancer: A preliminary studyHomogeneously staining regions in 223 breast carcinomas: cytogenetic and clinicopathological correlations.Prognostic factors for breast cancer and their use in the clinical setting.Classical gene amplifications in human breast cancer are not associated with distant solid metastasesPrognostic value of loss of heterozygosity at BRCA2 in human breast carcinomaEuropean multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables. Breast Cancer Somatic Genetics Consortium.Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma.
P2860
Q22254567-96DE0170-B565-4C4F-88A6-929960C53BAEQ24530212-1202F3C6-394D-46FA-B318-669A94DD82BAQ24532217-D0C4D50C-721C-49C0-9FF2-C27C703E9D6AQ24613036-1ECB785D-2444-442F-AD4D-3CF3A9F95ED2Q24630843-9DAED5EE-FCD5-44A6-BB78-FA7E165BD789Q24810612-9EB9D133-C0E9-4629-97F9-C8DF193DE765Q26783920-755382B8-2E2F-4288-AD0D-E90ADEDE9F1AQ28138383-E891D6FB-9810-44BD-B0DE-7ED449DE3B9FQ28257362-933FD0CE-D22A-4FA7-B305-34E33F97BD41Q28360494-C8DAE630-3F68-45F9-8359-1A7B21B4A604Q30693246-23101D32-496D-4CF5-9C82-827FC286CEFBQ32052529-C5C65D9C-98C9-499F-8267-DB3158E21151Q33369969-EA3D812A-22BD-41C9-A4EC-B4CAD6930164Q33449315-2FA0B31F-65C5-442D-B0C0-66FEA0ECF638Q33522049-A9E97335-B882-4AE4-9663-2FCD668488C9Q33536033-09C249A1-7733-4FDA-9A46-AAD581E950E4Q33643315-46A81F25-F873-461E-B3D0-F6127DD14263Q33748595-6A8980C6-172F-4F75-975A-024204E03DCCQ33936692-C08CBA01-197F-4254-82A0-05CDCDB797BDQ34068051-1007FB07-EB25-430F-A66D-82224A218EBEQ34082446-FFCA9265-DA63-466F-A4ED-9A72287A3FAEQ34130558-66794C0D-537D-4745-AC1D-7929BDFC4E87Q34167896-A6584139-E302-4527-9EDF-5EA3CE8198FDQ34194526-71B4E720-E6C8-4201-9728-A446ED00289FQ34272277-A650B879-2197-4D92-94D4-5E3BBCFA828BQ34292695-908FBD41-62BF-451A-8819-AE5A4D431CA8Q34464929-30E70D4F-0DF1-4933-9CCD-4E1FB721934EQ34569408-8422B92C-029D-4539-AF4D-F69BE71870E2Q34611561-9F1C3EB1-5DD2-4FCB-BDD6-A76D1E3150F6Q35753201-DE58C625-FEAB-4D1E-9950-4B49A750C850Q35759154-9C84248C-D660-446D-8741-D1EDD63CC9A1Q35764267-32DED687-11F7-4B8F-BD02-F9A824C4BB5BQ35782049-3E7A2C48-2CED-4967-AAA8-EE9C9CA8317FQ35995798-8E48CB96-6C5C-4F17-9E3A-1B9A60D1758FQ36115115-C09C001C-F853-4ADA-A589-922B4F864F9DQ36118398-278344A9-C21A-42D4-906B-13798A4E7AFEQ36431072-3F55DB12-4E43-4556-B09A-2653CBB9E08CQ36431503-28643696-4260-441B-A23A-95FD86B5A031Q36617728-586C9768-8158-41C8-A6CF-E87CE55B7AB0Q36618853-1EC64546-D338-4E93-98BD-5F4F82EC9A6F
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Genetic alterations in breast cancer.
@en
type
label
Genetic alterations in breast cancer.
@en
prefLabel
Genetic alterations in breast cancer.
@en
P2860
P356
P1476
Genetic alterations in breast cancer
@en
P2093
Lidereau R
P2860
P304
P356
10.1002/GCC.2870140402
P50
P577
1995-12-01T00:00:00Z